🔴 Fennec Pharmaceuticals is trading 9.3% down today with no clear company-specific catalyst identified

Fennec Pharmaceuticals is trading at $8.75, down 9.3% in after-hours trading, with no clear company-specific catalyst identified for the move.

• The stock closed the regular session at $9.65 before the decline.
• The drop likely reflects thin after-hours liquidity and broader risk-off sentiment rather than fundamental news, earnings releases, or FDA events.
• Traders should exercise caution, as extended-hours price swings often overshoot and can partially reverse by the next market open.